Epilepsy Trial, Recruiting NCT06202196 Sponsor: University Hospital, Montpellier Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT06202196
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 18 and 60 years old
  • People who have epilepsy that is poorly controlled, meaning seizures have continued for more than a year despite receiving appropriate treatment
  • People who have been seizure-free for more than a year, but where the treating doctor considers a therapeutic patient education (TPE) program would still be beneficial
  • People who are willing to take part in a therapeutic patient education (TPE) program

Who may not be able to join:

  • People with epilepsy who have already taken part in a therapeutic patient education program specifically for epilepsy
  • People who have significant difficulties with thinking, memory, or understanding (major cognitive impairment)
  • People who are under guardianship or a form of legal protection
  • Women who are pregnant or currently breastfeeding
  • People who do not provide written agreement to participate after being given time to consider it
  • People who, for geographical, social, or psychological reasons, would not be able to take part in the research
  • People where the treating doctor considers participation could present risks to the person or to the research
  • People who are currently taking part in another treatment-based research trial
  • People who are not covered by public health insurance

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 4.67.33.78.78

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
16 April 2024
Est. completion
16 April 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Change in the "safety management" sub-scale of the Epilepsy Self Management Scale (ESMS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov